Xuanzhu Biopharmaceutical Co., Ltd.

Financial

[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "alert": "No Quarterly Results declared by Xuanzhu Biopharmaceutical Co., Ltd."
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "header": "Annual Results Snapshot (Consolidated) - Dec'25",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in year ended Dec 2025 is 72.09% vs 0.00% in Dec 2024",
        "dir": 1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in year ended Dec 2025 is 55.86% vs -81.66% in Dec 2024",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Dec'25",
        "Dec'24",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "56.10",
          "val2": "32.60",
          "chgp": "72.09%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "-220.50",
          "val2": "-574.70",
          "chgp": "61.63%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "0.10",
          "val2": "0.30",
          "chgp": "-66.67%",
          "chgp_class": "positive"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "-266.30",
          "val2": "-603.30",
          "chgp": "55.86%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "-4,508.50%",
          "val2": "-18,734.00%",
          "chgp": "1,422.55%",
          "chgp_class": "positive"
        }
      ]
    }
  }
]

Annual Results Snapshot (Consolidated) - Dec'25

Dec'25

Dec'24

Change(%)

Net Sales

56.10

32.60

72.09%

Operating Profit (PBDIT) excl Other Income

-220.50

-574.70

61.63%

Interest

0.10

0.30

-66.67%

Exceptional Items

0.00

0.00

Consolidate Net Profit

-266.30

-603.30

55.86%

Operating Profit Margin (Excl OI)

-4,508.50%

-18,734.00%

1,422.55%

USD in Million.

Compare with Peers

Net Sales

YoY Growth in year ended Dec 2025 is 72.09% vs 0.00% in Dec 2024

Consolidated Net Profit

YoY Growth in year ended Dec 2025 is 55.86% vs -81.66% in Dec 2024

All Annual Results